Stay updated on ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe webpage has updated its date references to 2025 and modified the location formatting for Seoul, Korea. Additionally, there is a duplicate entry for the Henry Ford Health System.SummaryDifference2%
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check42 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this aspect.SummaryDifference0.2%
Stay in the know with updates to ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.